Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Nexplanon 68 mg implant for subdermal use

Active Ingredient:
etonogestrel
Company:  
Organon Pharma (UK) Limited See contact details
ATC code: 
G03AC08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Product Information HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Nexplanon 68 mg Implant: Patient Alert Card

The provision of this card to patients is required by the terms of the Marketing Authorisation. Please ensure that you store the card in a safe place, and show it to your healthcare professional at any visits related to the use of your implant. Ensure that you have read and understood this information as it contains important safety information that you need to be aware of following the insertion of Nexplanon.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Organon Pharma (UK) Limited
Company image
Address
The Hewett Building, 14 Hewett Street, London, EC2A 3NP, UK
WWW
https://www.organon.com/uk/
Telephone
+44 (0) 208 159 3593
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 208 159 3500